MedCity Company of the Month
Each month MedCity profiles an innovative, growing company from across the Greater South East of England. The Electrospinning Company is a pioneer in design and manufacture of implantable biomaterials and they have recently expanded into purpose-built cleanroom facilities at the Harwell Campus to increase their production capabilities. We spoke with Ann Kramer, CEO, about their work… Read more »
IDS 2019 – Cologne, Germany – 12-16 March 2019
IDS is the leading global trade fair for the dental community, which ensures sustainable success as a platform for innovation and market trends. Discover the dental future here in Cologne from 12-16 March 2019. Marco Thio will attend on behalf of The Electrospinning Company.
Innovation Loan for manufacturing scale-up
One of 17 businesses backed in the second round of innovation loans for innovative manufacturing processes and materials. The companies will use the funding to carry out R&D projects as part of plans to scale up production and commercialise new technologies. The Electrospinning Company has just moved into purpose-built clean-room facilities on the growing Harwell Science and Innovation… Read more »
We’ve moved!
Brand new, purpose-built facilities on the Harwell Science and Innovation Campus, a rapidly expanding innovation hub near Oxford in the UK. We are moving into our new unit (#5) in the Zephyr Building on 29th October. The 500 square metre unit is fitted out with four Class VII cleanroom modules, facilitating the segregation of R&D… Read more »
Materials Accelerator Forum – Manchester, UK – 13th November 2018
Materials accelerator forum The Royce works to accelerate the commercialisation of advanced materials, by directly supporting startups, spin-outs, SMEs and large corporates, with advice, expertise and facilities access. The Forum will share details of how to apply to the Royce for facilities access and ‘proof of concept’ funding, as well as sharing insights from successful… Read more »
Multiple sclerosis repair roadmap
Research published in the journal Nature provides new understanding about how drugs can repair damaged brain cells that cause disability in patients with multiple sclerosis. Led by researchers at Case Western Reserve University School of Medicine, the study suggests new drug targets and potent early-stage drug candidates could lead to regenerative medicines for multiple sclerosis… Read more »
ESB – Maastricht, Netherlands – Sept 9-13, 2018
Matei Cirstea and Marco Thio will be at the 29th European Conference on Biomaterials from September 9-13 in Maastricht, The Netherlands together with colleagues from the BONE consortium. The 29th Annual Meeting of the European Society for Biomaterials that will take place on September 9–13, 2018 in Maastricht, the Netherlands. The theme of this year’s conference… Read more »
EORS – Galway, Ireland – 25-28 Sept 2018
The EORS 2018 meeting will be held in Galway, Ireland. Ann Kramer is speaking on ‘The value of Diversity in growing a company’ in the Female leadership session (25th Sept 18:00-19:30) and Marco Thio is speaking on ‘Electrospinning applications in orthopaedic procedures’ (26th Sept 14:00-15:30. Meet them both at the exhibition booth. The European Orthopaedic Research… Read more »
IKC/Regener8 – Leeds, UK – 29th June
Rob McKean will attend IKC & Regener8 Annual Conference 2018 Date: June 29, 2018 @ 9:00 AM Location: Leeds The Medical Technologies IKC and Regener8 are back in 2018 to host a one-day conference on 29th June, focussing on best practice in translating regenerative devices – a potential £1bn industry in the UK. The full programme will… Read more »
Advanced Cell Culture: A Practical Approach – London – 8th June
Ann Kramer will present at the ECACC workshop Advanced Cell Culture: A Practical Approach on 8th June on the use of electrospun scaffolds in phenotypically relevant assays. Stephen Jones will be present at the exhibition stand to answer questions. A one day workshop in London, UK – Friday 8th June 2018 ECACC is excited to… Read more »
Bio – Boston – 4-7 June
Dr Kitty Lawton will attend the Bio convention in Boston from 4-7 June 2018.
UCL Innovation Forum – London – 24th April 2018
TECL’s CEO Ann Kramer will be speaking at this year’s Innovation Forum event on Regenerative Medicine. A new era in Regenerative Medicine: accelerating research from bench to bedside. You can register here. About the event Stem Cell Therapies, CAR-T, Cell and Gene Therapies, are the cutting-edge technologies of translational medicine in the 21st century. They… Read more »
